Covid vaccine patent landscape heats up as Pfizer's partner sues Arbutus and Genevant

Covid vaccine patent landscape heats up as Pfizer's partner sues Arbutus and Genevant

Source: 
Endpoints
snippet: 

The patent landscape around the two top Covid-19 vaccines is getting more complex and contested by the day.

Most recently, Canadian biotech Acuitas sued Arbutus and Genevant, two companies that Acuitas believes are making baseless claims about being near the heart of Pfizer and BioNTech’s and Moderna’s wildly successful Covid-19 vaccines.